Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 13
Submit an article Journal homepage
513
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Survivorship in AML – a landmark analysis on the outcomes of acute myelogenous leukemia patients after maintaining complete remission for at least 3 years

Catherine Kendall Majora Eastern Virginia Medical School, Norfolk, VA, USAORCID Iconhttps://orcid.org/0000-0003-1507-331XView further author information
ORCID Icon,
Hagop Kantarjianb Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Koji Sasakib Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Gautam Borthakurb Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0001-7679-6453View further author information
ORCID Icon,
Tapan Kadiab Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Naveen Pemmarajub Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Courtney DiNardob Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Nicholas J. Shortb Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Naval Daverb Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Elias Jabbourb Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Richard Champlinb Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Guillermo Garcia-Manerob Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Marina Konoplevab Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Michael Andreeffb Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Steven Kornblaub Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
William Wierdab Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Sherry Pierceb Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Farhad Ravandib Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USAView further author information
&
Jorge Cortesc Georgia Cancer Center, Augusta University, Augusta, GA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8636-1071View further author information
ORCID Icon show all
Pages 3120-3127 | Received 15 May 2020, Accepted 21 Jul 2020, Published online: 05 Aug 2020

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Jayastu Senapati, Rishi Dhawan, Mukul Aggarwal, Pradeep Kumar, Ganesh Kumar Vishwanathan, Jasmita Dass, Seema Tyagi, Manoranjan Mahapatra & Tulika Seth. (2021) Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country. Leukemia & Lymphoma 62:6, pages 1514-1517.
Read now
Wen Liu & Fanjun Cheng. (2021) Circular RNA circCRKL inhibits the proliferation of acute myeloid leukemia cells via the miR-196a-5p/miR-196b-5p/p27 axis. Bioengineered 12:1, pages 7704-7713.
Read now
Strachan Mackenzie & Saar Gill. (2020) Long-term outcomes in patients with AML achieving first complete remission: confronting the double-hit of survivorship. Leukemia & Lymphoma 61:13, pages 3035-3037.
Read now

Articles from other publishers (8)

Dan Wang, Fenglin Wang, Haixia Zhang, Pan Chen & Minghua Yang. (2023) Circadian clock protein Bmal1 accelerates acute myeloid leukemia by inhibiting ferroptosis through the EBF3/ALOX15 axis. Cancer Science 114:8, pages 3446-3460.
Crossref
Gaku Oshikawa & Koji Sasaki. (2023) Optimizing Treatment Options for Newly Diagnosed Acute Myeloid Leukemia in Older Patients with Comorbidities. Cancers 15:8, pages 2399.
Crossref
Gabriel Heering, Maya Sasson, Dan Dominissini, Avichai Shimoni, Abraham Avigdor, Arnon Nagler & Jonathan Canaani. (2022) Contemporary evaluation of acute myeloid leukemia patients with long‐term survival exceeding 5 years. European Journal of Haematology 109:6, pages 765-771.
Crossref
Ginna Granroth, Nandita Khera & Cecilia Arana Yi. (2022) Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults. Current Hematologic Malignancy Reports 17:6, pages 243-253.
Crossref
Saro H. Armenian, Yanjun Chen, Lindsay Hageman, Jessica Wu, Wendy Landier, Alysia Bosworth, Liton Francisco, Elizabeth Schlichting, Ravi Bhatia, Donna Salzman, F. Lennie Wong, Daniel J. Weisdorf, Stephen J. Forman, Mukta Arora & Smita Bhatia. (2022) Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study. Journal of Clinical Oncology 40:28, pages 3278-3288.
Crossref
Anna S. Moret, Dennis Görlich, Maria C. Sauerland, Klaus H. Metzeler & Eva Telzerow. (2022) Langzeitfolgen der Akuten Myeloischen Leukämie und ihrer BehandlungLong-term effects of acute myeloid leukemia and its treatment. best practice onkologie 17:9, pages 412-417.
Crossref
Anna S. Moret, Dennis Görlich, Maria C. Sauerland, Klaus H. Metzeler & Eva Telzerow. (2022) Langzeitfolgen der Akuten Myeloischen Leukämie und ihrer BehandlungLong-term effects of acute myeloid leukemia and its treatment. Die Onkologie 28:6, pages 519-523.
Crossref
Lina Nunez, Tasnima Abedin, Syed Naqvi, Hua Shen, Ahsan Chaudhry, Scott Bellerby, Lynn Savoie, Andrew Daly, Mona Shafey, Peter Duggan, Jan Storek & Kareem Jamani. (2022) Cumulative incidence of subsequent malignancy after allo-HCT conditioned with or without low-dose total body irradiation. Blood Advances 6:3, pages 767-773.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.